[HTML][HTML] Erlotinib (tarceva) for the treatment of non–small-cell lung cancer and pancreatic cancer
CM Rocha-Lima, LE Raez - Pharmacy and Therapeutics, 2009 - ncbi.nlm.nih.gov
Erlotinib (Tarceva) is a small-molecule, orally dosed, anti-cancer drug that inhibits the
epidermal growth factor receptor. Randomized, controlled clinical studies have …
epidermal growth factor receptor. Randomized, controlled clinical studies have …
Erlotinib (tarceva) for the treatment of non-small-cell lung cancer and pancreatic cancer.
CM Rocha-Lima, LE Raez - P & T: a Peer-reviewed Journal for …, 2009 - europepmc.org
Erlotinib (Tarceva) is a small-molecule, orally dosed, anti-cancer drug that inhibits the
epidermal growth factor receptor. Randomized, controlled clinical studies have …
epidermal growth factor receptor. Randomized, controlled clinical studies have …
[PDF][PDF] Erlotinib (Tarceva) for the Treatment of Non–Small-Cell Lung Cancer and Pancreatic Cancer
CM Rocha-Lima, LE Raez - academia.edu
Erlotinib (Tarceva) is a small-molecule, orally dosed, anticancer drug that inhibits the
epidermal growth factor receptor. Randomized, controlled clinical studies have …
epidermal growth factor receptor. Randomized, controlled clinical studies have …
Erlotinib (tarceva) for the treatment of non-small-cell lung cancer and pancreatic cancer
CM Rocha-Lima, LE Raez - P & T: a peer-reviewed …, 2009 - pubmed.ncbi.nlm.nih.gov
Erlotinib (Tarceva) is a small-molecule, orally dosed, anti-cancer drug that inhibits the
epidermal growth factor receptor. Randomized, controlled clinical studies have …
epidermal growth factor receptor. Randomized, controlled clinical studies have …